Advertisement
Screener

SPECTRUM PHARMACEUTICALS INC Patents: Active

SPECTRUM PHARMACEUTICALS INC Active Patents

2 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2022-01-28: Application 17586872; Invention Methods of Treatment Using G-CSF Protein Complex; Applicant Spectrum Pharmaceuticals, Inc.; Status Patented Case.
  • 2021-07-13: Application 17374302; Invention METHODS OF TREATING CHEMOTHERAPY INDUCED NEUTROPENIA USING FIXED DOSES OF EFLAPEGRASTIM; Applicant Spectrum Pharmaceuticals, Inc.; Status Patented Case.
FiledApplicationInventionApplicantStatusGrantedPatentPublished asInventor nameInventor countryExaminer
2022-01-2817586872Methods of Treatment Using G-CSF Protein ComplexSpectrum Pharmaceuticals, Inc.Patented Case2025-01-2112202871US20220153799A1
Gajanan Bhat
Shanta Chawla
United States
United States
CHANDRA, GYAN
2021-07-1317374302METHODS OF TREATING CHEMOTHERAPY INDUCED NEUTROPENIA USING FIXED DOSES OF EFLAPEGRASTIMSpectrum Pharmaceuticals, Inc.Patented Case2024-12-2412171804US20220016212A1
John A. Barrett
Sribalaji Lakshmikanthan
United States
United States
STOICA, ELLY GERALD